These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 33656758)

  • 1. Acceptability of ENG-releasing subdermal implants among postpartum Brazilian young women during the COVID-19 pandemic.
    Barbieri MM; Herculano TB; Dantas Silva A; Bahamondes L; Juliato CRT; Surita FG
    Int J Gynaecol Obstet; 2021 Jul; 154(1):106-112. PubMed ID: 33656758
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ENG-releasing subdermal implants in postpartum teenagers - an open-label trial study protocol.
    Barbieri MM; Juliato CRT; Bahamondes L; Surita FG
    Reprod Health; 2020 Jun; 17(1):100. PubMed ID: 32576199
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Extended use up to 5 years of the etonogestrel-releasing subdermal contraceptive implant: comparison to levonorgestrel-releasing subdermal implant.
    Ali M; Akin A; Bahamondes L; Brache V; Habib N; Landoulsi S; Hubacher D;
    Hum Reprod; 2016 Nov; 31(11):2491-2498. PubMed ID: 27671673
    [TBL] [Abstract][Full Text] [Related]  

  • 4. One-year follow-up of immediate postpartum contraceptive implant insertion in adolescents.
    Barbieri MM; Dantas-Silva A; Caleffi LS; Morais SS; Juliato CRT; Bahamondes L; Surita FG
    Eur J Contracept Reprod Health Care; 2023 Feb; 28(1):58-64. PubMed ID: 36287505
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Timing of postpartum etonogestrel-releasing implant insertion and bleeding patterns, weight change, 12-month continuation and satisfaction rates: a randomized controlled trial.
    Vieira CS; de Nadai MN; de Melo Pereira do Carmo LS; Braga GC; Infante BF; Stifani BM; Ferriani RA; Quintana SM
    Contraception; 2019 Oct; 100(4):258-263. PubMed ID: 31145885
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Postpartum weight loss in overweight and obese women using the etonogestrel subdermal implant: a pilot study.
    Griffin L; Hammond C; Liu D; Rademaker AW; Kiley J
    Contraception; 2017 Jun; 95(6):564-570. PubMed ID: 28238839
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acceptability of long-acting, progestin-only contraception in Europe: a two-year prospective, non-interventional study.
    Short M; Dallay D; Omokanye S; Stauch K; Inki P
    Eur J Contracept Reprod Health Care; 2014 Feb; 19(1):29-38. PubMed ID: 24289528
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A 3-year multicentre randomized controlled trial of etonogestrel- and levonorgestrel-releasing contraceptive implants, with non-randomized matched copper-intrauterine device controls.
    Bahamondes L; Brache V; Meirik O; Ali M; Habib N; Landoulsi S;
    Hum Reprod; 2015 Nov; 30(11):2527-38. PubMed ID: 26409014
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Informing Policy Change: A Study of Rapid Repeat Pregnancy in Adolescents to Increase Access to Immediate Postpartum Contraception.
    Qasba NT; Stutsman JW; Weaver GE; Jones KE; Daggy JK; Wilkinson TA
    J Womens Health (Larchmt); 2020 Jun; 29(6):815-818. PubMed ID: 31990605
    [No Abstract]   [Full Text] [Related]  

  • 10. Effectiveness and continuation rates of the etonogestrel-subdermal contraceptive implant versus short-acting contraceptive methods offered at no cost in Campinas, Brazil.
    Laporte M; Marcelino AC; da Cunha Pereira P; Espejo-Arce X; Juliato CT; Bahamondes L
    Int J Gynaecol Obstet; 2024 Jul; 166(1):305-311. PubMed ID: 38328989
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immediate versus delayed insertion of an etonogestrel releasing implant at medical abortion-a randomized controlled equivalence trial.
    Hognert H; Kopp Kallner H; Cameron S; Nyrelli C; Jawad I; Heller R; Aronsson A; Lindh I; Benson L; Gemzell-Danielsson K
    Hum Reprod; 2016 Nov; 31(11):2484-2490. PubMed ID: 27664217
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bioequivalence and x-ray visibility of a radiopaque etonogestrel implant versus a non-radiopaque implant: a 3-year, randomized, double-blind study.
    Schnabel P; Merki-Feld GS; Malvy A; Duijkers I; Mommers E; van den Heuvel MW
    Clin Drug Investig; 2012 Jun; 32(6):413-22. PubMed ID: 22540269
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ongoing Etonogestrel Contraceptive Implant Use Throughout Pregnancy.
    Lazorwitz A; Coleman-Minahan K; Teal SB; Guiahi M
    J Adolesc Health; 2018 Sep; 63(3):363-364. PubMed ID: 30076014
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of Immediate Postpartum Etonogestrel Implant Insertion and Venous Thromboembolism.
    Floyd JL; Beasley AD; Swaim LS; Turrentine MA; Nijjar JB
    Obstet Gynecol; 2020 Jun; 135(6):1275-1280. PubMed ID: 32459418
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Twelve-month discontinuation of etonogestrel implant in an outpatient pediatric setting.
    Berlan E; Mizraji K; Bonny AE
    Contraception; 2016 Jul; 94(1):81-6. PubMed ID: 26948183
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of immediate postpartum compared to delayed postpartum and interval etonogestrel contraceptive implant insertion on removal rates for bleeding.
    Ireland LD; Goyal V; Raker CA; Murray A; Allen RH
    Contraception; 2014 Sep; 90(3):253-8. PubMed ID: 24973904
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-acting reversible contraceptive acceptability and unintended pregnancy among women presenting for short-acting methods: a randomized patient preference trial.
    Hubacher D; Spector H; Monteith C; Chen PL; Hart C
    Am J Obstet Gynecol; 2017 Feb; 216(2):101-109. PubMed ID: 27662799
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immediate postpartum etonogestrel implant: a contraception option with long-term continuation.
    Wilson S; Tennant C; Sammel MD; Schreiber C
    Contraception; 2014 Sep; 90(3):259-64. PubMed ID: 24993485
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Etonogestrel-Releasing Contraceptive Implant for Postpartum Adolescents: A Randomized Controlled Trial.
    Bryant AG; Bauer AE; Stuart GS; Levi EE; Zerden ML; Danvers A; Garrett JM
    J Pediatr Adolesc Gynecol; 2017 Jun; 30(3):389-394. PubMed ID: 27561981
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A 12-month multicenter, randomized study comparing the levonorgestrel intrauterine system with the etonogestrel subdermal implant.
    Apter D; Briggs P; Tuppurainen M; Grunert J; Lukkari-Lax E; Rybowski S; Gemzell-Danielsson K
    Fertil Steril; 2016 Jul; 106(1):151-157.e5. PubMed ID: 27016644
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.